Amylin Can't Block Lilly's Rival Drug Sales: 9th Circ.
The Ninth Circuit on Monday affirmed a ruling denying Amylin Pharmaceuticals Inc.'s request to block Eli Lilly & Co. from allegedly violating a joint marketing agreement and breaching antitrust laws by...To view the full article, register now.
Already a subscriber? Click here to view full article